Show More News: Watch more newsNews search related to the stock Celgene Corporati (ordered by date):
Healthcare Nanotechnology (Nanomedicine) Market Scope of ... Digital Journal
Marginal Zone Lymphoma Pipeline Appears Robust With 50+ Key ... Digital Journal
Stronger enforcement and sanctions for pharmaceutical infringements Lexology
Nanobiotechnology Market: Year 2023-2030 and its Detail Analysis ... Digital Journal
Increasing Opportunities In Tissue Regenerative Therapy Market ... Digital Journal
Adenoid Cystic Carcinoma Pipeline Analysis Demonstrates Novel 5 ... Digital Journal
Bridging the Gap to Reach Treatment Goals in DLBCL cme.healio.com
Advanced Therapy Medicinal Products Market ? A Comprehensive ... Trends In Globe
Global Psoriasis Drugs Market 2023: Topical Products to Account for ... Digital Journal
AAD 2023 : Incyte Presentations and Posters Marketscreener.com
Multiple Sclerosis Drugs Market: The Multiple Sclerosis Drugs ... Digital Journal
Single Cell Analysis Market is expected to grow at a significant CAGR of 17.8% EIN News
Kessler Topaz Meltzer & Check, LLP Announces Pendency of Class ... PR Newswire
Cancer Drugs Market to See Massive Growth by 2029 | Johnson and ... Digital Journal
Celgene Must Face Humana Suit on 'Supracompetitive' Drug Prices Bloomberg Law
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a ... Business Wire
Bristol Myers must face a lawsuit filed by former Celgene shareholders FiercePharma
Bristol-Myers Squibb to Acquire Celgene to Create a Premier ... Business Wire
Wellington Management Does Not Support Bristol-Myers Squibb's ... Business Wire
Natco Pharma launches additional strengths of cancer drug Revlimid CNBCTV18
Gene Therapy Market Report (2022 to 2030) - Novartis AG, Spark ... Yahoo Finance
Celgene Corporation and Acceleron Pharma Announce U.S. FDA ... Business Wire
Sun Pharma gets U.S. FDA nod to market generic medication The Hindu
Kyn Therapeutics Enters into Global Strategic Collaboration with ... Business Wire
Patent settlement and licence agreements Maddocks
Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its ... Business Wire
Celgene Completes Acquisition of Juno Therapeutics, Inc ... Business Wire
HealthCor Offshore Master Fund LP et al v. Celgene Corporation et ... OffshoreAlert
Celgene signs deal with BeiGene for tumor cancer treatment Reuters
Editas Medicine and Celgene Corporation Amend Existing ... GlobeNewswire
Celgene (CELG) Updates on R&D Deep Dive (Multiple Myeloma ... Seeking Alpha
ACCC delivers bitter pill on patent settlement Allens
Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid Economic Times
Celgene Corporation: How to Effectively Buy Into CELG Stock Yahoo Finance
Teva and Natco Announce Launch of additional strengths for the ... Business Wire
Celgene buys EngMab for $600M and will head into clinic next year FierceBiotech
BioMarin Appoints Former CEO of Celgene Corporation, Mark Alles ... PR Newswire
Vividion Therapeutics Announces Strategic Research Collaboration ... PR Newswire
Bristol-Myers/Celgene: Win-Win Merger (NASDAQ:CELG) Seeking Alpha
Why Celgene's Beaten Down Stock Can Rise 28% Investopedia
Celgene Can't Delay Cancer Drug Antitrust Case, Court Told Law360
Bristol Myers Squibb - LOTTE to Purchase Bristol Myers Squibb ... news.bms.com
Celgene to pay $280 million to settle off-label marketing case Reuters
Pancreatic Cancer Treatment Market Research Update, Size ... Digital Journal
Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion Reuters.com
Celgene, sold for $74 billion, leaves a legacy of chutzpah in science ... STAT
Celgene, Bristol-Myers set $2.2 billion termination fee for their mega ... Reuters.com
Celgene to Acquire Delinia, Inc. Business Wire
Ankylosing Spondylitis Market Growth and Status Explored in a New Research Report 2032 openPR
Generic Revlimid Could Sink Celgene (NASDAQ:CELG) Seeking Alpha
Celgene and Juno Announce Celgene Exercised Option to Develop ... Business Wire
Celgene In 2018: A Look At The Long Thesis (NASDAQ:CELG) Seeking Alpha
Is Celgene A Growth Or A Value Stock? (NASDAQ:CELG) Seeking Alpha
Skyhawk Therapeutics Announces Strategic Collaboration with ... PR Newswire
Osteogenesis Imperfecta Treatment Market Size Is Estimated To ... Medgadget
Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter ... news.bms.com
Celgene to buy Abraxis BioScience for $2.9 billion Reuters.com
Bristol-Myers Squibb: Great Deal On Celgene And Undervalued ... Seeking Alpha
Celgene to Acquire Avila Therapeutics Business Wire
With Bristol-Myers CVR, Investors Can Bet on 3 Drugs in Celgene?s Pipeline Barron's
It had to happen: Ex-Celgene shareholders sue Bristol Myers ... FiercePharma
Celgene & Juno: The Latest in a Bumper Crop of Biotech M&A? Barron's
Celgene Stock History: The Biotech's Path to Gigantic Gains The Motley Fool
FDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of ... Business Wire
'Major blunder': Ex-staffers blast Bristol Myers Squibb's handling of ... FiercePharma
Soon-Shiong's NantCell gets $30M from Celgene - L.A. Business First The Business Journals
Celgene (CELG) Stock Will Eventually Break Out of Sideways Trend TheStreet
Olympic Swimmer and Author Dara Torres Teams Up With Celgene ... Business Wire
Acceleron Pharma Announces Global Collaboration with Celgene ... FierceBiotech
Bristol Myers Squibb - Bristol Myers Squibb Data at ASCO and EHA ... news.bms.com
Bristol-Myers: Fattening Up The Pipeline With Celgene (NYSE:BMY) Seeking Alpha
Dragonfly Therapeutics Announces Strategic Collaboration with ... PR Newswire
Should You Own Celgene In 2017? Part 7 (NASDAQ:CELG) Seeking Alpha
Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal Reuters
Better Buy: Geron vs. Celgene The Motley Fool
Antengene Corporation Appoints Former Celgene ANZ General ... PR Newswire
Celgene takes its most aggressive price hikes yet on Revlimid ... FiercePharma
Celgene bags a build-to-buy biotech in $485M cancer deal FierceBiotech
Seven Habits Of Celgene's Highly Successful Strategy Forbes
Gene Therapy Market Size, Growth, Trends, Report 2022-2028 openPR
Bristol-Myers Squibb defends Celgene takeover as 'best path' Financial Times
FACIT and Triphase Accelerator Announce New Partnership with ... GlobeNewswire
Celgene Appoints Tuomo Pätsi as President of EMEA and Commits ... Business Wire
Should You Own Celgene In 2017? Part 6 (NASDAQ:CELG) Seeking Alpha
Patent Infringement Suit Against Bristol-Myers, Celgene Targets ... Law.com
Former Celgene, Portola Lawyers Land New Big Pharma Roles Bloomberg Law
A 7-year-old alliance between Celgene and Acceleron is paying off ... Endpoints News
Regenacy Pharmaceuticals to be Launched by Acetylon ... Business Wire
Deal of the Year: Bristol-Myers Squibb buys Celgene BioPharma Dive
Editas Expands Its Celgene Partnership After Another Strong Quarter The Motley Fool
Celgene COO Scott Smith exits suddenly in wake of MS fumble ... FiercePharma
BMS reveals its post-Celgene takeover management team pharmaphorum
FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for ... Business Wire
Why It's Time That Markets Assign More Value To Celgene's Drug ... Seeking Alpha
Should You Own Celgene In 2017? Part 2 (NASDAQ:CELG) Seeking Alpha
Celgene pays high upfront to extend deal with Forma BioPharma Dive
Bad year at Celgene? Forget about it. CEO Mark Alles nabbed a big ... Endpoints News
Celgene Stock Split: Is the Biotech Ready to Split Again? The Motley Fool
Prothena Announces Global Neuroscience Research ... GlobeNewswire